Literature DB >> 24171625

Biochemical and functional characterization of charge-defined subfractions of high-density lipoprotein from normal adults.

Ju-Yi Hsieh1, Chiz-Tzung Chang1,2, Max T Huang3, Chia-Ming Chang1, Chia-Ying Chen1, Ming-Yi Shen1,4, Hsin-Yi Liao5, Guei-Jane Wang4,6,7, Chu-Huang Chen1,4,3,8, Chao-Jung Chen5,3, Chao-Yuh Yang1,4,3,8.   

Abstract

High-density lipoprotein (HDL) is regarded as atheroprotective because it provides antioxidant and anti-inflammatory benefits and plays an important role in reverse cholesterol transport. In this paper, we outline a novel methodology for studying the heterogeneity of HDL. Using anion-exchange chromatography, we separated HDL from 6 healthy individuals into five subfractions (H1 through H5) with increasing charge and evaluated the composition and biologic activities of each subfraction. Sodium dodecyl sulfate polyacrylamide gel electrophoresis analysis showed that apolipoprotein (apo) AI and apoAII were present in all 5 subfractions; apoCI was present only in H1, and apoCIII and apoE were most abundantly present in H4 and H5. HDL-associated antioxidant enzymes such as lecithin-cholesterol acyltransferase, lipoprotein-associated phospholipase A2, and paraoxonase 1 were most abundant in H4 and H5. Lipoprotein isoforms were analyzed in each subfraction by using matrix-assisted laser desorption-time-of-flight mass spectrometry. To quantify other proteins in the HDL subfractions, we used the isobaric tags for the relative and absolute quantitation approach followed by nanoflow liquid chromatography-tandem mass spectrometry analysis. Most antioxidant proteins detected were found in H4 and H5. The ability of each subfraction to induce cholesterol efflux from macrophages increased with increasing HDL electronegativity, with the exception of H5, which promoted the least efflux activity. In conclusion, anion-exchange chromatography is an attractive method for separating HDL into subfractions with distinct lipoprotein compositions and biologic activities. By comparing the properties of these subfractions, it may be possible to uncover HDL-specific proteins that play a role in disease.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24171625      PMCID: PMC3919464          DOI: 10.1021/ac402516u

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  66 in total

Review 1.  High-density lipoproteins and endothelial function.

Authors:  B J O'Connell; J Genest
Journal:  Circulation       Date:  2001-10-16       Impact factor: 29.690

Review 2.  Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy.

Authors:  Elias J Jeyarajah; William C Cromwell; James D Otvos
Journal:  Clin Lab Med       Date:  2006-12       Impact factor: 1.935

3.  Uremia alters HDL composition and function.

Authors:  Michael Holzer; Ruth Birner-Gruenberger; Tatjana Stojakovic; Dalia El-Gamal; Veronika Binder; Christian Wadsack; Akos Heinemann; Gunther Marsche
Journal:  J Am Soc Nephrol       Date:  2011-07-29       Impact factor: 10.121

4.  Apolipoprotein C-III0 lacks carbohydrate residues: use of mass spectrometry to study apolipoprotein structure.

Authors:  Y Ito; J L Breslow; B T Chait
Journal:  J Lipid Res       Date:  1989-11       Impact factor: 5.922

Review 5.  High-density lipoprotein--the clinical implications of recent studies.

Authors:  D J Gordon; B M Rifkind
Journal:  N Engl J Med       Date:  1989-11-09       Impact factor: 91.245

6.  Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures.

Authors:  B J Van Lenten; S Y Hama; F C de Beer; D M Stafforini; T M McIntyre; S M Prescott; B N La Du; A M Fogelman; M Navab
Journal:  J Clin Invest       Date:  1995-12       Impact factor: 14.808

7.  Oxidation of high density lipoproteins. II. Evidence for direct reduction of lipid hydroperoxides by methionine residues of apolipoproteins AI and AII.

Authors:  B Garner; A R Waldeck; P K Witting; K A Rye; R Stocker
Journal:  J Biol Chem       Date:  1998-03-13       Impact factor: 5.157

8.  Opposing effects of apolipoproteins E and C on lipoprotein binding to low density lipoprotein receptor-related protein.

Authors:  R C Kowal; J Herz; K H Weisgraber; R W Mahley; M S Brown; J L Goldstein
Journal:  J Biol Chem       Date:  1990-06-25       Impact factor: 5.157

9.  Non enzymatic glycation of apolipoprotein A-I. Effects on its self-association and lipid binding properties.

Authors:  C Calvo; C Talussot; G Ponsin; F Berthézène
Journal:  Biochem Biophys Res Commun       Date:  1988-06-30       Impact factor: 3.575

10.  Interaction of free apolipoproteins with macrophages. Formation of high density lipoprotein-like lipoproteins and reduction of cellular cholesterol.

Authors:  H Hara; S Yokoyama
Journal:  J Biol Chem       Date:  1991-02-15       Impact factor: 5.157

View more
  11 in total

Review 1.  Rethinking reverse cholesterol transport and dysfunctional high-density lipoproteins.

Authors:  Baiba K Gillard; Corina Rosales; Bingqing Xu; Antonio M Gotto; Henry J Pownall
Journal:  J Clin Lipidol       Date:  2018-04-12       Impact factor: 4.766

Review 2.  Deepening our understanding of HDL proteome.

Authors:  Graziella Eliza Ronsein; Tomáš Vaisar
Journal:  Expert Rev Proteomics       Date:  2019-08-27       Impact factor: 3.940

Review 3.  Mass Spectrometry-Based Proteomic Study Makes High-Density Lipoprotein a Biomarker for Atherosclerotic Vascular Disease.

Authors:  Chiz-Tzung Chang; Chao-Yuh Yang; Fuu-Jen Tsai; Shih-Yi Lin; Chao-Jung Chen
Journal:  Biomed Res Int       Date:  2015-05-18       Impact factor: 3.411

Review 4.  Antioxidative activity of high-density lipoprotein (HDL): Mechanistic insights into potential clinical benefit.

Authors:  Fernando Brites; Maximiliano Martin; Isabelle Guillas; Anatol Kontush
Journal:  BBA Clin       Date:  2017-08-19

5.  A Novel Cell-Free, Non-Fluorescent Method to Measure LOX-1-Binding Activity Corresponding to The Functional Activity of HDL.

Authors:  Akemi Kakino; Yoko Usami; Sayaka Horiuchi; Yoshiko Fujita; Kazuhiko Kotani; Chu-Huang Chen; Tomonori Okamura; Tatsuya Sawamura
Journal:  J Atheroscler Thromb       Date:  2019-04-03       Impact factor: 4.928

Review 6.  Apolipoprotein C1: Its Pleiotropic Effects in Lipid Metabolism and Beyond.

Authors:  Elena V Fuior; Anca V Gafencu
Journal:  Int J Mol Sci       Date:  2019-11-26       Impact factor: 5.923

7.  An Increased Plasma Level of ApoCIII-Rich Electronegative High-Density Lipoprotein May Contribute to Cognitive Impairment in Alzheimer's Disease.

Authors:  Hua-Chen Chan; Liang-Yin Ke; Hsiao-Ting Lu; Shih-Feng Weng; Hsiu-Chuan Chan; Shi-Hui Law; I-Ling Lin; Chuan-Fa Chang; Ye-Hsu Lu; Chu-Huang Chen; Chih-Sheng Chu
Journal:  Biomedicines       Date:  2020-11-26

8.  The Potential Role of Electronegative High-Density Lipoprotein H5 Subfraction in RA-Related Atherosclerosis.

Authors:  Ching-Kun Chang; Wei-Chung Cheng; Wen-Lung Ma; Po-Ku Chen; Chu-Huang Chen; Pei-Chun Shen; Chia-Ching Chen; Shih-Hsin Chang; Yi-Hua Lai; Der-Yuan Chen
Journal:  Int J Mol Sci       Date:  2021-10-22       Impact factor: 5.923

Review 9.  Dysfunctional High-Density Lipoprotein: An Innovative Target for Proteomics and Lipidomics.

Authors:  Juan Salazar; Luis Carlos Olivar; Eduardo Ramos; Mervin Chávez-Castillo; Joselyn Rojas; Valmore Bermúdez
Journal:  Cholesterol       Date:  2015-11-08

10.  Apolipoprotein C-III in the high-density lipoprotein proteome of cerebral lacunar infarction patients impairs its anti-inflammatory function.

Authors:  Pu Lv; Mingming Zhao; Yuanyuan Liu; Haiqiang Jin; Wei Cui; Chenghe Fan; Yuming Teng; Lemin Zheng; Yining Huang
Journal:  Int J Mol Med       Date:  2017-10-27       Impact factor: 4.101

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.